Despite a recent share price drop, the company's long-term p...
Despite a recent share price drop, the company's long-term performance and EPS growth remain impressive. The market appears pessimistic, but if fundamentals indicate sustainable growth, the current sell-off could be a potential opportunity.
Those Who Invested in Zhejiang Jiuzhou Pharmaceutical (SHSE:603456) Five Years Ago Are up 174%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment